Bloomsbury Genetic Therapies
About:
Bloomsbury Genetic Therapies develops curative treatments for rare neurological and metabolic diseases using gene therapy technologies.
Website: https://bloomsburygtx.com/
Top Investors: UCL Technology Fund
Description:
Bloomsbury Genetic Therapies develops curative treatments for rare neurological and metabolic diseases using gene therapy technologies.
Total Funding Amount:
5M GBP
Headquarters Location:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2022-10-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-10-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai